Privia Health (PRVA) Cost of Revenue (2020 - 2026)

Privia Health has reported Cost of Revenue for 7 years, with the latest figure at $8.1 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 17.51% year-over-year to $8.1 million; the trailing twelve-month figure through Mar 2026 stood at $28.3 million (up 3.9% YoY), and the FY2025 full-year result was $27.1 million, up 2.61% from the prior year.
• Cost of Revenue for Q1 2026 stood at $8.1 million, up from $6.4 million in the prior quarter.
• The five-year high for Cost of Revenue was $8.1 million in Q1 2026, with the low at $4.7 million in Q1 2022.
• Average Cost of Revenue over 5 years is $6.2 million, with a median of $6.4 million recorded in 2025.
• Peak annual rise in Cost of Revenue reached 46.39% in 2022, while the deepest fall reached 56.89% in 2022.
• Tracing PRVA's Cost of Revenue over 5 years: stood at $5.2 million in 2022, then advanced by 20.8% to $6.2 million in 2023, then rose by 3.41% to $6.5 million in 2024, then retreated by 0.2% to $6.4 million in 2025, then increased by 26.13% to $8.1 million in 2026.
• The last three Cost of Revenue figures came in at $8.1 million (Q1 2026), $6.4 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.

Peer Comparison